_id
69171ace3c536f8df23165ca
Ticker
SXTPW
Name
60 Degrees Pharmaceuticals, Inc. Warrant
Exchange
NASDAQ
Address
-
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
-
Description
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Last Close
0.0503
Volume
1200
Current Price
0.0598
Change
0.0005
Last Updated
2026-01-07T12:43:53.562Z
Image
-
Ipo Date
2023-07-12T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
437602
Cost Of Revenue
537690
Gross Profit
-100088
Operating Expenses
2225437
Operating Income
-2325525
Interest Expense
1708
Pretax Income
-2316786
Net Income
-2317036
Eps
-0.6304161688759912
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
250
EBITDA
-2315078
Operating Margin
-531.424673561821
Total Other Income Expense Net
8739
Cash
4115779
Short Term Investments
0
Receivables
674036
Inventories
527004
Total Current Assets
6309209
Property Plant Equipment
227752
Total Assets
6689344
Payables
1391347
Short Term Debt
-
Long Term Debt
144992
Total Liabilities
144992
Equity
4346958
Bs_currency_symbol
USD
Depreciation
22830
Change In Working Capital
-127537
Cash From Operations
3047494
Capital Expenditures
57166
Cash From Investing
-25487
Cash From Financing
4282178
Net Change In Cash
2148849
Cf_currency_symbol
USD
PE
-
PB
0.050561643015644496
ROE
-53.30247037123432
ROA
-34.63771634408396
FCF
2990328
Fcf Percent
6.833442260318737
Piotroski FScore
2
Health Score
53
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
6
Growth Investing Score
4.5
Momentum Investing Score
4.5
Net Net Investing Score
3.5
Quality Investing Score
4.5
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
437602
Quarters > 0 > income Statement > cost Of Revenue
537690
Quarters > 0 > income Statement > gross Profit
-100088
Quarters > 0 > income Statement > operating Expenses
2225437
Quarters > 0 > income Statement > operating Income
-2325525
Quarters > 0 > income Statement > interest Expense
1708
Quarters > 0 > income Statement > pretax Income
-2316786
Quarters > 0 > income Statement > net Income
-2317036
Quarters > 0 > income Statement > eps
-0.6304161688759912
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3675407
Quarters > 0 > income Statement > income Tax Expense
250
Quarters > 0 > income Statement > EBITDA
-2315078
Quarters > 0 > income Statement > operating Margin
-531.424673561821
Quarters > 0 > income Statement > total Other Income Expense Net
8739
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4115779
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
674036
Quarters > 0 > balance Sheet > inventories
527004
Quarters > 0 > balance Sheet > total Current Assets
6309209
Quarters > 0 > balance Sheet > property Plant Equipment
227752
Quarters > 0 > balance Sheet > total Assets
6689344
Quarters > 0 > balance Sheet > payables
1391347
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
144992
Quarters > 0 > balance Sheet > total Liabilities
144992
Quarters > 0 > balance Sheet > equity
4346958
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2316324
Quarters > 0 > cash Flow > depreciation
22830
Quarters > 0 > cash Flow > change In Working Capital
-127537
Quarters > 0 > cash Flow > cash From Operations
3047494
Quarters > 0 > cash Flow > capital Expenditures
57166
Quarters > 0 > cash Flow > cash From Investing
-25487
Quarters > 0 > cash Flow > cash From Financing
4282178
Quarters > 0 > cash Flow > net Change In Cash
2148849
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6304161688759912
Quarters > 0 > ratios > PB
0.050561643015644496
Quarters > 0 > ratios > ROE
-53.30247037123432
Quarters > 0 > ratios > ROA
-34.63771634408396
Quarters > 0 > ratios > FCF
2990328
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
6.833442260318737
Quarters > 0 > health Score
53
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
100932
Quarters > 1 > income Statement > cost Of Revenue
50051
Quarters > 1 > income Statement > gross Profit
50881
Quarters > 1 > income Statement > operating Expenses
1862648
Quarters > 1 > income Statement > operating Income
-1604828
Quarters > 1 > income Statement > interest Expense
1221
Quarters > 1 > income Statement > pretax Income
-1733430
Quarters > 1 > income Statement > net Income
-1734930
Quarters > 1 > income Statement > eps
-1.177907937518798
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1472891
Quarters > 1 > income Statement > income Tax Expense
1500
Quarters > 1 > income Statement > EBITDA
-1604828
Quarters > 1 > income Statement > operating Margin
-1590.009115047755
Quarters > 1 > income Statement > total Other Income Expense Net
-128602
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1966930
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
295034
Quarters > 1 > balance Sheet > inventories
799421
Quarters > 1 > balance Sheet > total Current Assets
3844355
Quarters > 1 > balance Sheet > property Plant Equipment
193879
Quarters > 1 > balance Sheet > total Assets
4181938
Quarters > 1 > balance Sheet > payables
905813
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
145477
Quarters > 1 > balance Sheet > total Liabilities
145477
Quarters > 1 > balance Sheet > equity
2345704
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
1877301
Quarters > 1 > cash Flow > depreciation
-16797
Quarters > 1 > cash Flow > change In Working Capital
-81480
Quarters > 1 > cash Flow > cash From Operations
1597366
Quarters > 1 > cash Flow > capital Expenditures
5482
Quarters > 1 > cash Flow > cash From Investing
-51684
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-1484570
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.177907937518798
Quarters > 1 > ratios > PB
0.03754901803467104
Quarters > 1 > ratios > ROE
-73.96201737303598
Quarters > 1 > ratios > ROA
-41.486267849977686
Quarters > 1 > ratios > FCF
1591884
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
15.771846391630008
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
163552
Quarters > 2 > income Statement > cost Of Revenue
73272
Quarters > 2 > income Statement > gross Profit
90280
Quarters > 2 > income Statement > operating Expenses
2093886
Quarters > 2 > income Statement > operating Income
-1910875
Quarters > 2 > income Statement > interest Expense
1790
Quarters > 2 > income Statement > pretax Income
-1877238
Quarters > 2 > income Statement > net Income
-1876549
Quarters > 2 > income Statement > eps
-1.462099384321468
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1283462
Quarters > 2 > income Statement > income Tax Expense
63
Quarters > 2 > income Statement > EBITDA
-1910875
Quarters > 2 > income Statement > operating Margin
-1168.359298571708
Quarters > 2 > income Statement > total Other Income Expense Net
33637
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3451500
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
488243
Quarters > 2 > balance Sheet > inventories
773238
Quarters > 2 > balance Sheet > total Current Assets
5650231
Quarters > 2 > balance Sheet > property Plant Equipment
155792
Quarters > 2 > balance Sheet > total Assets
5977867
Quarters > 2 > balance Sheet > payables
1157979
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
146502
Quarters > 2 > balance Sheet > total Liabilities
146502
Quarters > 2 > balance Sheet > equity
4028889
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1876550
Quarters > 2 > cash Flow > depreciation
16797
Quarters > 2 > cash Flow > change In Working Capital
81480
Quarters > 2 > cash Flow > cash From Operations
-1597366
Quarters > 2 > cash Flow > capital Expenditures
5482
Quarters > 2 > cash Flow > cash From Investing
1702518
Quarters > 2 > cash Flow > cash From Financing
1696899
Quarters > 2 > cash Flow > net Change In Cash
1792147
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.462099384321468
Quarters > 2 > ratios > PB
0.019050171796740987
Quarters > 2 > ratios > ROE
-46.57733186493845
Quarters > 2 > ratios > ROA
-31.39161510284521
Quarters > 2 > ratios > FCF
-1602848
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-9.800234787712776
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
230846
Quarters > 3 > income Statement > cost Of Revenue
118077
Quarters > 3 > income Statement > gross Profit
112769
Quarters > 3 > income Statement > operating Expenses
2306676
Quarters > 3 > income Statement > operating Income
-2075830
Quarters > 3 > income Statement > interest Expense
1422
Quarters > 3 > income Statement > pretax Income
-2049425
Quarters > 3 > income Statement > net Income
-2045037
Quarters > 3 > income Statement > eps
-3.607352515752115
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
566908
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-899.22719042132
Quarters > 3 > income Statement > total Other Income Expense Net
27827
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1659353
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
486748
Quarters > 3 > balance Sheet > inventories
442764
Quarters > 3 > balance Sheet > total Current Assets
5386277
Quarters > 3 > balance Sheet > property Plant Equipment
149808
Quarters > 3 > balance Sheet > total Assets
5759345
Quarters > 3 > balance Sheet > payables
1007618
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
147119
Quarters > 3 > balance Sheet > total Liabilities
1804339
Quarters > 3 > balance Sheet > equity
4035600
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2045040
Quarters > 3 > cash Flow > depreciation
15947
Quarters > 3 > cash Flow > change In Working Capital
218929
Quarters > 3 > cash Flow > cash From Operations
-1638217
Quarters > 3 > cash Flow > capital Expenditures
2098
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
973
Quarters > 3 > cash Flow > net Change In Cash
-1641335
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-3.607352515752115
Quarters > 3 > ratios > PB
0.008400510060461889
Quarters > 3 > ratios > ROE
-50.67491822777283
Quarters > 3 > ratios > ROA
-35.50815240274719
Quarters > 3 > ratios > FCF
-1640315
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-7.105667847829289
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
607574
Annuals > 0 > income Statement > cost Of Revenue
384765
Annuals > 0 > income Statement > gross Profit
222809
Annuals > 0 > income Statement > operating Expenses
10011511
Annuals > 0 > income Statement > operating Income
-9714931
Annuals > 0 > income Statement > interest Expense
7912
Annuals > 0 > income Statement > pretax Income
-7955413
Annuals > 0 > income Statement > net Income
-7955663
Annuals > 0 > income Statement > eps
-17.50105151545816
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
454582
Annuals > 0 > income Statement > income Tax Expense
250
Annuals > 0 > income Statement > EBITDA
-9714931
Annuals > 0 > income Statement > operating Margin
-1598.97082495301
Annuals > 0 > income Statement > total Other Income Expense Net
1759518
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1659353
Annuals > 0 > balance Sheet > short Term Investments
1728472
Annuals > 0 > balance Sheet > receivables
486748
Annuals > 0 > balance Sheet > inventories
442764
Annuals > 0 > balance Sheet > total Current Assets
5386277
Annuals > 0 > balance Sheet > property Plant Equipment
149808
Annuals > 0 > balance Sheet > total Assets
5759345
Annuals > 0 > balance Sheet > payables
1007618
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
147119
Annuals > 0 > balance Sheet > total Liabilities
147119
Annuals > 0 > balance Sheet > equity
3955006
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-7947107
Annuals > 0 > cash Flow > depreciation
63745
Annuals > 0 > cash Flow > change In Working Capital
192724
Annuals > 0 > cash Flow > cash From Operations
-5648088
Annuals > 0 > cash Flow > capital Expenditures
181114
Annuals > 0 > cash Flow > cash From Investing
-1889114
Annuals > 0 > cash Flow > cash From Financing
7053571
Annuals > 0 > cash Flow > net Change In Cash
-483132
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-17.50105151545816
Annuals > 0 > ratios > PB
0.0074135257949039775
Annuals > 0 > ratios > ROE
-201.1542586787479
Annuals > 0 > ratios > ROA
-138.1348573492298
Annuals > 0 > ratios > FCF
-5829202
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-9.594225559355733
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
253573
Annuals > 1 > income Statement > cost Of Revenue
474550
Annuals > 1 > income Statement > gross Profit
-220977
Annuals > 1 > income Statement > operating Expenses
5408156
Annuals > 1 > income Statement > operating Income
-5154583
Annuals > 1 > income Statement > interest Expense
2286637
Annuals > 1 > income Statement > pretax Income
-3813550
Annuals > 1 > income Statement > net Income
-3765702
Annuals > 1 > income Statement > eps
-38.88822107937295
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
96834
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-2032.7806982604613
Annuals > 1 > income Statement > total Other Income Expense Net
3627670
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2142485
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
231332
Annuals > 1 > balance Sheet > inventories
466169
Annuals > 1 > balance Sheet > total Current Assets
7242588
Annuals > 1 > balance Sheet > property Plant Equipment
71278
Annuals > 1 > balance Sheet > total Assets
7783771
Annuals > 1 > balance Sheet > payables
506206
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
150251
Annuals > 1 > balance Sheet > total Liabilities
2985675
Annuals > 1 > balance Sheet > equity
4870134
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-3986420
Annuals > 1 > cash Flow > depreciation
100372
Annuals > 1 > cash Flow > change In Working Capital
405364
Annuals > 1 > cash Flow > cash From Operations
-4542910
Annuals > 1 > cash Flow > capital Expenditures
115888
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
6474565
Annuals > 1 > cash Flow > net Change In Cash
1877620
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-38.88822107937295
Annuals > 1 > ratios > PB
0.0012824684084667896
Annuals > 1 > ratios > ROE
-77.3223488306482
Annuals > 1 > ratios > ROA
-48.37888987227399
Annuals > 1 > ratios > FCF
-4658798
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-18.372610648610063
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
223208
Annuals > 2 > income Statement > cost Of Revenue
432370
Annuals > 2 > income Statement > gross Profit
-209162
Annuals > 2 > income Statement > operating Expenses
1973653
Annuals > 2 > income Statement > operating Income
-1750445
Annuals > 2 > income Statement > interest Expense
3989359
Annuals > 2 > income Statement > pretax Income
-6177284
Annuals > 2 > income Statement > net Income
-6181720
Annuals > 2 > income Statement > eps
-66.59542149205494
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
92825
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-2109139
Annuals > 2 > income Statement > operating Margin
-784.2214436758538
Annuals > 2 > income Statement > total Other Income Expense Net
-437480
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
264865
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
45965
Annuals > 2 > balance Sheet > inventories
518578
Annuals > 2 > balance Sheet > total Current Assets
1099004
Annuals > 2 > balance Sheet > property Plant Equipment
33947
Annuals > 2 > balance Sheet > total Assets
1297206
Annuals > 2 > balance Sheet > payables
758668
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
1270055
Annuals > 2 > balance Sheet > total Liabilities
25446266
Annuals > 2 > balance Sheet > equity
-23576740
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-6181720
Annuals > 2 > cash Flow > depreciation
78786
Annuals > 2 > cash Flow > change In Working Capital
3369555
Annuals > 2 > cash Flow > cash From Operations
-1009980
Annuals > 2 > cash Flow > capital Expenditures
60133
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1221706
Annuals > 2 > cash Flow > net Change In Cash
149466
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-66.59542149205494
Annuals > 2 > ratios > PB
-0.0002539457321071531
Annuals > 2 > ratios > ROE
26.219570644626867
Annuals > 2 > ratios > ROA
-476.5411199146473
Annuals > 2 > ratios > FCF
-1070113
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.794241245833483
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1160340
Annuals > 3 > income Statement > cost Of Revenue
850742
Annuals > 3 > income Statement > gross Profit
309598
Annuals > 3 > income Statement > operating Expenses
2284442
Annuals > 3 > income Statement > operating Income
-1124102
Annuals > 3 > income Statement > interest Expense
3172712
Annuals > 3 > income Statement > pretax Income
-4259299
Annuals > 3 > income Statement > net Income
-4251745
Annuals > 3 > income Statement > eps
-45.80387826555346
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
92825
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-1014802
Annuals > 3 > income Statement > operating Margin
-96.87694985952393
Annuals > 3 > income Statement > total Other Income Expense Net
37515
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
115399
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
146362
Annuals > 3 > balance Sheet > inventories
689042
Annuals > 3 > balance Sheet > total Current Assets
1176672
Annuals > 3 > balance Sheet > property Plant Equipment
107615
Annuals > 3 > balance Sheet > total Assets
1393527
Annuals > 3 > balance Sheet > payables
588678
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
18744795
Annuals > 3 > balance Sheet > total Liabilities
19548011
Annuals > 3 > balance Sheet > equity
-17578228
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4251745
Annuals > 3 > cash Flow > depreciation
71785
Annuals > 3 > cash Flow > change In Working Capital
2896491
Annuals > 3 > cash Flow > cash From Operations
-649106
Annuals > 3 > cash Flow > capital Expenditures
35392
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
611226
Annuals > 3 > cash Flow > net Change In Cash
-76303
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-45.80387826555346
Annuals > 3 > ratios > PB
-0.0003406038708793628
Annuals > 3 > ratios > ROE
24.187563160518796
Annuals > 3 > ratios > ROA
-305.106754300419
Annuals > 3 > ratios > FCF
-684498
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.5899115776410363
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.6304161688759912
Valuation > metrics > PB
0.050561643015644496
Valuation > final Score
70
Valuation > verdict
94.9% Undervalued
Profitability > metrics > ROE
-53.30247037123432
Profitability > metrics > ROA
-36.72466706999245
Profitability > metrics > Net Margin
-5.2948478297631185
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.033354819623285986
Risk > metrics > Interest Coverage
-1361.5485948477751
Risk > final Score
-5386
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.534604954766856
Liquidity > metrics > Quick Ratio
4.1558324415117145
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-5197
Prev Risks > 1
-4210
Prev Risks > 2
-5779
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:39:42.008Z
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACan CXW stock sustain double digit ROE - Trade Volume Report & Pattern Based Trade Signal System bollywoodhelpline.com
Read more →Can Supreme Power Equipment Limited (SUPREMEPWR) Maintain Its Valuation - Market Rumors and News & Explosive Capital Growth Plans bollywoodhelpline.com
Read more →Showing 2 of 9
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of 60 Degrees Pharmaceuticals, Inc. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.